Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

作者: H. Shelton Earp , Thomas L. Dawson , Xiong Li , Hong Yu

DOI: 10.1007/BF00694752

关键词:

摘要: The EGF receptor (EGFR) and HER2 are members of a growth factor family. Overexpression either protein in advanced breast cancer correlates with poor prognosis. stimulates by binding to EGFR, activating the receptor's intracellular tyrosine kinase. initial consequence is phosphorylation specific tyrosine-containing sequences carboxyl terminus. These phosphotyrosines serves as high affinity recognition sites for proteins that, turn, transmit signal inside cell. Mechanistic studies suggest that binds single triggering dimerization another like molecule. This thought initiate kinase activation. family was recently expanded sequencing HER3 HER4. Each four postulated regulate unique or differentiation signaling repertoire when activated receptor-specific ligand. However, new data from numerous laboratories EGFR may play complex ultimately more flexible role forming heterodimers between members, e.g. EGFR:HER2 HER4:HER2. form even only one member pair its review summarizes current work on heterodimerization attempts predict consequences downstream signaling. In brief, compared ligand-dependent homodimers comprised two same internalization sequence phosphorylated residues, likely to: i) expand substrate selection pathway activation; ii) promote interaction sets substrates mixed complexes would not ordinarily be physically juxtaposed; iii) alter duration changing rates internalization, ligand loss, inactivation, recycling, etc.; iv) dephosphorylation. addition understanding interactions machinery, identification each will necessary explicate differentiation.

参考文章(95)
MARC E. LIPPMAN, ROBERT B. DICKSON, Mechanisms of growth control in normal and malignant breast epithelium. Recent Progress in Hormone Research. ,vol. 45, pp. 383- 440 ,(1989) , 10.1016/B978-0-12-571145-6.50012-1
G. Carpenter, M. I. Wahl, The Epidermal Growth Factor Family Springer, New York, NY. pp. 69- 171 ,(1991) , 10.1007/978-1-4612-3210-0_4
P. P. Di Fiore, O. Segatto, T. Pawson, G. Digiesi, J. Mcglade, G. Pelicci, S. Giuli, P. G. Pelicci, Shc products are substrates of erbB-2 kinase. Oncogene. ,vol. 8, pp. 2105- 2112 ,(1993)
K.L. Carraway, M.X. Sliwkowski, R. Akita, J.V. Platko, P.M. Guy, A. Nuijens, A.J. Diamonti, R.L. Vandlen, L.C. Cantley, R.A. Cerione, The erbB3 gene product is a receptor for heregulin. Journal of Biological Chemistry. ,vol. 269, pp. 14303- 14306 ,(1994) , 10.1016/S0021-9258(17)36789-3
Jeffrey L Wrana, Liliana Attisano, Rotraud Wieser, Francesc Ventura, Joan Massagué, None, Mechanism of activation of the TGF-β receptor Nature. ,vol. 370, pp. 341- 347 ,(1994) , 10.1038/370341A0
DK Graham, TL Dawson, HR Snodgrass, DL Mullaney, HS Earp, Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth & Differentiation. ,vol. 5, pp. 647- 657 ,(1994)
C Y Cheung, J E Kudlow, J D Bjorge, Epidermal growth factor stimulates the synthesis of its own receptor in a human breast cancer cell line. Journal of Biological Chemistry. ,vol. 261, pp. 4134- 4138 ,(1986) , 10.1016/S0021-9258(17)35635-1
I. Lax, F. Bellot, R. Howk, A. Ullrich, D. Givol, J. Schlessinger, Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. The EMBO Journal. ,vol. 8, pp. 421- 427 ,(1989) , 10.1002/J.1460-2075.1989.TB03393.X